Subcortical brain segmentation of two dimensional T1-weighted data sets with FMRIB's Integrated Registration and Segmentation Tool (FIRST)  by Amann, Michael et al.
NeuroImage: Clinical 7 (2015) 43–52
Contents lists available at ScienceDirect
NeuroImage: Clinical
j ourna l homepage: www.e lsev ie r .com/ locate /yn ic lSubcortical brain segmentation of two dimensional T1-weighted data
sets with FMRIB3s Integrated Registration and Segmentation Tool (FIRST)Michael Amann a,b,⁎, Michaela Andělová a, Armanda Pﬁster a, Nicole Mueller-Lenke b,c, Stefan Traud c,
Julia Reinhardt b, Stefano Magon a, Kerstin Bendfeldt c, Ludwig Kappos a, Ernst-Wilhelm Radue b,c,
Christoph Stippich b, Till Sprenger a,b
aDepartment of Neurology, University Hospital Basel, Petersgraben 4, Basel 4031, Switzerland
bDivision of Diagnostic and Interventional Neuroradiology, Department of Radiology, Petersgraben 4, Basel 4031, Switzerland
cMedical Image Analysis Center (MIAC), Schanzenstrasse 55, Basel 4031, Switzerland* Corresponding author at: Department of Neurolo
Petersgraben 4, Basel 4031, Switzerland. Tel.: +41 61 265
E-mail address:Michael.Amann@usb.ch (M. Amann).
http://dx.doi.org/10.1016/j.nicl.2014.11.010
2213-1582/© 2014 The Authors. Published by Elsevier Inca b s t r a c ta r t i c l e i n f oArticle history:
Received 1 September 2014
Received in revised form 5 November 2014
Accepted 12 November 2014
Available online 18 November 2014
Keywords:
Segmentation
Basal ganglia
T1-weighted data
Two-dimensional data
Multiple sclerosis
FMRIB3s Integrated Registration and
Segmentation ToolBrain atrophy has been identiﬁed as an important contributing factor to the development of disability inmultiple
sclerosis (MS). In this respect, more and more interest is focussing on the role of deep grey matter (DGM) areas.
Novel data analysis pipelines are available for the automatic segmentation of DGMusing three-dimensional (3D)
MRI data. However, in clinical trials, often no such high-resolution data are acquired and hence no conclusions
regarding the impact of new treatments on DGM atrophy were possible so far. In this work, we used FMRIB3s In-
tegrated Registration and Segmentation Tool (FIRST) to evaluate the possibility of segmenting DGM structures
using standard two-dimensional (2D) T1-weighted MRI. In a cohort of 70 MS patients, both 2D and 3D T1-
weighted data were acquired. The thalamus, putamen, pallidum, nucleus accumbens, and caudate nucleus
were bilaterally segmented using FIRST. Volumeswere calculated for each structure and for the sum of basal gan-
glia (BG) as well as for the total DGM. The accuracy and reliability of the 2D data segmentation were compared
with the respective results of 3D segmentations using volume difference, volume overlap and intra-class corre-
lation coefﬁcients (ICCs). The mean differences for the individual substructures were between 1.3% (putamen)
and−25.2% (nucleus accumbens). The respective values for the BGwere−2.7% and for DGM1.3%.Mean volume
overlap was between 89.1% (thalamus) and 61.5% (nucleus accumbens); BG: 84.1%; DGM: 86.3%. Regarding ICC,
all structures showed good agreement with the exception of the nucleus accumbens. The results of the segmen-
tation were additionally validated through expert manual delineation of the caudate nucleus and putamen in a
subset of the 3D data. In conclusion, we demonstrate that subcortical segmentation of 2D data are feasible
using FIRST. The larger subcortical GM structures can be segmented with high consistency. This forms the basis
for the application of FIRST in large 2D MRI data sets of clinical trials in order to determine the impact of thera-
peutic interventions on DGM atrophy in MS.
© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Several grey matter nuclei are located in the depth of the brain and
hence being termed deep grey matter (DGM). These nuclei include
the thalamus, globus pallidus (pallidum), putamen, nucleus accumbens
and caudate nucleus. All these areas serve as relay stations to and be-
tween cortical brain areas. The pallidum, putamen and caudate nucleus
are usually grouped as basal ganglia (BG), because of a common in-
volvement in extrapyramidal motor functions. These areas receive in-
puts from multiple cortical areas and the thalamus and project mostly
to the premotor, supplementary motor and prefrontal areas. They aregy, University Hospital Basel,
78 38; fax: +41 61 265 43 55.
. This is an open access article underimplicated in voluntary and automatic motor responses, predicting fu-
ture events, suppressing unwanted behaviour, shifting attention and
are involved in spatial workingmemory (Herrero et al., 2002). The thal-
amus is a complex of 50–60 nuclei that serves as a relay and ﬁlter centre
for both sensory and motor pathways. First order nuclei receive input
mostly from ascending sensory pathways, whereas higher order nuclei
receive primary afferents from the cerebral cortex (Herrero et al.,
2002). Thalamic damage can be associated with motor and somatosen-
sory disturbances, cognitive decline, fatigue and central pain.
DGM involvement is increasingly recognized as an important patho-
physiological feature of multiple sclerosis (MS). Histopathological stud-
ies have shown demyelination, inﬂammation, iron accumulation and
neurodegeneration of DGM in MS patients (Bagnato et al., 2011;
Vercellino et al., 2009). Moreover, DGM abnormalities have been re-
ported using magnetic resonance (MR) imaging. Using arterial spinthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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poperfusion inMS patients, a ﬁnding thatwas corroborated by dynamic
contrast-enhanced perfusion MR (Inglese et al., 2007; Varga et al.,
2009). Increased iron accumulation has been shown by means of sus-
ceptibility weighted imaging as well as by quantitative T2 studies
(Bakshi et al., 2002; Drayer et al., 1987; Haacke et al., 2009) and may
precede DGM atrophy (Hagemeier et al., 2012).
Several studies demonstrated a close relationship between DGM at-
rophy and the clinical manifestation of MS. For example, Houtchens
et al. (2007) found signiﬁcant correlation between cognitive perfor-
mance and thalamic volume in MS patients and a reduction of thalamic
volume compared to healthy controls. A correlation between atrophy of
the putamen and the clinical outcome has been reported by Henry et al.
(2008) in a cohort of patients with clinically isolated syndrome sugges-
tive of multiple sclerosis (CIS). Atrophy of DGM structures may predict
conversion of CIS to deﬁnite MS (Calabrese et al., 2010), correlates
with memory impairment (Benedict et al., 2009), information process-
ing slowing (Batista et al., 2012) and may be associated with develop-
ment of fatigue (Calabrese et al., 2010). There is some evidence that
DGM atrophy correlates with (Tao et al., 2009) or is even driven by
WM lesions (Muhlau et al., 2013).
Several methods have been previously used to assess DGM atrophy:
1. indirect measures such as the bicaudate ratio (Bermel et al., 2002;
Caon et al., 2003); 2. morphometric methods including voxel based
morphometry (Audoin et al., 2010; Henry et al., 2008; Lansley et al.,
2013; Prinster et al., 2006; Riccitelli et al., 2012) and tensor based mor-
phometry (Tao et al., 2009) and 3. volumetric methods with manual
(Bermel et al., 2003), semiautomatic (Houtchens et al., 2007) or fully
automatic DGM segmentation (Calabrese et al., 2010; Schoonheim
et al., 2012; Zivadinov et al., 2013).
A dedicated and frequently used method to automatically segment
subcortical grey matter structures based on three-dimensional (3D)
T1weighted (T1w)MRI data is FMRIB3s IntegratedRegistration and Seg-
mentation Tool (FIRST) (Patenaude et al., 2011), which is part of the
FMRIB Software Library (FSL) (Jenkinson et al., 2012; Smith et al.,
2004; Woolrich et al., 2009). FIRST uses a shape model obtained from
manually segmented images to guide the segmentation of the subcorti-
cal structures including the thalamus, basal ganglia, hippocampus and
amygdala. In brief, the individual 3D data set is registered by a two-
stage afﬁne transformation to a standard space (MNI space). Then,
FIRST ﬁts a mesh to the registered data set. This mesh represents the
surfaces of the subcortical structures. It is modelled using a multivariate
Gaussianmodel based on shape and intensity information (for a further
description see Patenaude et al. (2011)). FIRST has been extensively
evaluated for segmenting 3D data in terms of scan–rescan reliability
(Morey et al., 2010) as well as interscanner reliability (Nugent et al.,
2013). Furthermore, results have been comparedwithmanual segmen-
tations (Morey et al., 2009; Nugent et al., 2013) and other automatedFig. 1.Modiﬁed MNI template: Left — original MNI 1 mm T1w template used isegmentation tools (Morey et al., 2010; Nugent et al., 2013). To date,
FIRST has been applied successfully not only in studies covering various
neurological and psychiatric disorders such as epilepsy (Lin et al., 2012),
schizophrenia (Felsky et al., 2012), mild cognitive impairment (Alves
et al., 2012; Zhuang et al., 2013), Alzheimer3s disease (Alves et al.,
2012; Cheng et al., 2013; Park et al., 2012) and depression (Turner
et al., 2012), but also in research focussing on normal aging (Hughes
et al., 2012), cognitive ﬂexibility in older adults (Verstynen et al.,
2012) and topographical memory in young adults (Hartley and
Harlow, 2012).
In the aforementioned studies, FIRSTwas applied to 3D data sets. The
three-dimensional MRI acquisition provides data with high spatial reso-
lution as well as isotropic voxels and allows whole head coverage. To
date, however, no 3D data are acquired in many multicentre clinical
MS trials (e.g. (Barkhof et al., 2007; Khatri et al., 2011; Radue et al.,
2012)). Instead, only two-dimensional (2D) T1w data are acquired.
This relates to speciﬁc challenges in the multicentre setting, where
shorter scanning times are advantageous and not all sites may have ac-
cess to state-of-the-artMRI scanner hardware.Moreover, study sponsors
often aim at comparing data of new trials to previous studies favouring
the continued use of older sequences. Finally, 3D sequences are prone
to movement artefacts. On the other hand, segmentation of DGM using
2DMRI data using existing automatic segmenting tools seems to be chal-
lenging. One reason is that two dimensional data acquisition provides an
anisotropic spatial resolution with relatively large voxel dimensions in
the slice direction, typically in the range of 3–5 mm. Additionally, 2D
T1w data may suffer from suboptimal tissue contrast between the
DGM and the adjacent white matter (WM) structures.
Altogether, segmentation of DGM using 2D MRI data seems to be
challenging using automatic segmentation tools. In the original paper
of Patenaude et al. (2011), a training data set was used for FIRST,
which also encompassed 2D data. However to our knowledge, no sys-
tematic comparison between 2 and 3D segmentation has been carried
out so far. In this work, we investigated the feasibility and reliability of
applying the FIRST segmentation tool on 2D T1w data sets. We did so
by comparing DGM volumes of 70MS patients obtained by 2D data seg-
mentation with the respective results of 3D data segmentation in the
same subjects. The results of the segmentation were additionally vali-
dated through expert manual delineation of the caudate nucleus and
putamen in a subset of the 3D data.
In our opinion, the validation of FIRST on 2Ddata sets is important as
a large amount of such data has been collected in the last two decades in
most clinical multiple sclerosis trials (Gold et al., 2013; Kappos et al.,
2008; Kappos et al., 2010; Kappos et al., 2014; Miller et al., 2003;
Molyneux et al., 2000; Rovaris et al., 2007; Rudick et al., 2006). A suc-
cessful validation would form the basis for the application of FIRST in
these trials in order to determine the impact of therapeutic interven-
tions on DGM atrophy in MS.n FIRST, in yellow the subcortical mask; right —modiﬁed “cut” templates.
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2.1. Patients and image acquisition
Seventy consecutive patients with MS (47 women, 23 men) who
underwent clinical routine MRI head examinations at our institution
were included in this study. The study was approved by the local ethics
committee (Ethikkommission beider Basel, EKBB) and the participants
gave written informed consent before study entry. Sixty-two patients
had relapsing–remitting MS, three patients had secondary progressive
MS, one patient had primary progressive MS, and four patients had a
clinically isolated syndrome suggestive of MS. The mean age of the pa-
tients was 45.3 years (range 24 years–74 years, standard deviation:
11.2 years). The MR scans were performed on either one of the follow-
ing three 1.5 Tesla scanners (all Siemens Medical, Erlangen, Germany):
47 patients onMagnetomAvanto, 16 patients onMagnetom Symphony,
and 7 patients onMagnetom Espree. The standard scanning protocol on
each scanner included two pre-contrast T1w scans: an isotropic 3D
MPRAGE sequence (TR/TI/TE/α= 2.7 s/950 ms/5 ms/8°) and a 2D T1
weighted spin echo (SE) sequence with (TR/TE = 552 ms/17 ms) for
the Magnetom Avanto and Magnetom Espree; for the Magnetom Sym-
phony, the sequence parameters were slightly different (TR/TE =
450ms/10ms) to gain optimal image quality. In theMPRAGE sequence,
192 sagittal slices with a spatial resolution of 1 × 1 × 1 mm3 were ac-
quired, in the T1 weighted SE, 40 slices parallel to the inferior borders
of the corpus callosum were scanned with two interleaved concatena-
tions (spatial resolution 0.9 × 0.9 × 3 mm3). All head scans were ac-
quired with a standard 12-element head matrix coil.
2.2. Data processing
All data were processed using FIRST as part of FSL version 5.0. The
initial step of the FIRST data processing pipeline is a two-stage afﬁne
registration to a standard space template (MNI space) with 1 mm reso-
lution using 12 degrees of freedom. The whole brain is registered to the
template and thereafter the registration is reﬁned for the subcortical
structures using a mask. To enable this two-stage registration, the 2D
data were interpolated with a sinc function to an isotropic resolution
of 1 × 1 × 1 mm3 using FLIRT (FMRIB3s Linear Image Registration Tool,
also part of FSL (Jenkinson et al., 2002; Jenkinson and Smith, 2001)). Be-
sides this data interpolation, a slight modiﬁcation of the FIRST data pro-
cessing pipeline was necessary as the spatial head coverage of the 2D
slices was less than that of the original MNI template with only partial
inclusion of scalp and medulla oblongata. Therefore, we removed the
twenty most superior axial slices as well as the twenty most inferior
slices in both MNI template and subcortical mask (see Fig. 1) and used
these two modiﬁed templates in the further processing of the interpo-
lated 2D data sets. Except for this modiﬁcation, both 2D and 3D data
were processed identically. In our study, the following subcorticalFig. 2. Impact of atrophy: In this case, both registration of the 2D and 3D data toMNI space failed
registered to MNI space (slice is not identical but similar); C: 50% overlay to the MNI templatestructureswere segmented bilaterally: thalamus, caudate, pallidum, pu-
tamen and nucleus accumbens. Although it is possible to segment the
amygdala and hippocampus with FIRST, we decided not to include
these two structures in the analysis as it is challenging to control their
anatomical boundaries visually. Also the brainstem and 4th ventricle
were excluded from evaluation as these structures were only partially
covered in the 2D data.
Even after spatial interpolation, the 2D data demonstrated partial
volume effects, which were most obvious at the borders of the lateral
ventricles to thalamus bilaterally (see Fig. 6A). To reduce these partial
volume effects, a ventricle mask was calculated for both the 2D and
the 3D data sets using SIENAX (Smith et al., 2001; Smith et al., 2002)
and applied to the subcortical segmentation. SIENAX is also part of FSL
and has been extensively used for cross-sectional estimation of brain at-
rophy. It offers the possibility to segment a ventricular CSFmask (option
“–r”), which was used in this work.
The processed data setswere visually inspected for quality control at
three stages of the FIRST routine: First, the results of the two-step regis-
tration of the head were checked. If either the brain outline or the sub-
cortical structures were not well aligned to the MNI template, the
respective data sets were considered as having failed the analysis. Sec-
ond, the subcortical segmentation was screened for apparent inaccura-
cies. Third, the ventricle masks were checked for correctness.
For each bilateral subcortical structure, we obtained two volumes
(left and right) for each data set (in units ofmm3). In the statistical eval-
uation of these data, we found no signiﬁcant effects of laterality (results
not shown). Therefore, left- and right-sided volumes were pooled for
each structure in the statistical evaluation. This means that for N suc-
cessfully segmented data sets, statistical analyses were carried out
over 2 ∗ N volumes for each bilateral structure.
The results of the FIRST segmentation were additionally validated
through expert manual delineation. An experienced rater segmented
caudate and putamen manually according to Nugent et al. (2013). The
manual segmentations were restricted to a subset of twenty randomly
selected 3D data sets (9 from Avanto, 5 from Symphony, and 6 from
Espree), because the manual segmentation of brain structures is very
time consuming. The pallidum, thalamus and nucleus accumbens
were not outlined as the majority of their boundaries possess very low
tissue contrast to the adjacent WM and GM structures and a manual
segmentation using T1 data sets is therefore very difﬁcult in these struc-
tures. As the 2D SE data demonstrate even less tissue contrast than the
3D MPRAGE data in all DGM structures, manual segmentation was not
feasible in these data sets.2.3. Statistical analysis
In the statistical analyses, only patients whose 2D and 3D data sets
survived all three visual quality control steps were included. Thebecause of severely enlarged ventricles. A: Original axial view of the 3D data; B: same data
D: MNI template (for comparison).
Fig. 3. Impact of motion artefacts: Motion artefacts can hamper the registration to MNI space. A: The 2D data set show step-like artefacts due to motion between the two concatenated
acquisitions. The registration to MNI space fails in this case as can be seen of the deviation of the pitch angle of the registered data set (B) compared to the MNI template (C).
46 M. Amann et al. / NeuroImage: Clinical 7 (2015) 43–52analyseswere carried out using IBM SPSS Statistics 21 (IBMCorporation
Software Group, Somers, USA).
The agreement between the automatic segmentation results of the
2D and 3D data and the validation of FIRST with manual segmentation
were tested by means of: 1. Percentage difference in volume (ΔV), 2.
Percentage overlap in volume (Dice coefﬁcient s) and 3. Intraclass corre-
lation coefﬁcients.
Percentage differences in volume between the two segmentations
were calculated for each subcortical structure in all patients according
to Eq. (1):
ΔV ¼ 2  ðVð2DÞ−Vð3DÞÞ
Vð2DÞ þ Vð3DÞ ð1Þ
With
V(2D): volume of the segmented substructure in the 2D data
V(3D): volume of the segmented substructure in the 3D data.
With this deﬁnition, ΔV is the difference between the two volumes
normalized to the mean volume of each methods.
Additionally, also the percentage volume differences between all
basal ganglia (BG; sum of caudate, pallidum, putamen and nucleus ac-
cumbens) and between the whole deep grey matter (DGM; sum of BG
and thalamus) were calculated, as these overall measures are often sur-
veyed in clinical trials.
Another very commonmeasure of similarity between two structures
is the Dice3s similarity coefﬁcient (Dice, 1945). In our case Dice3s coefﬁ-
cient equals the percentage overlap of the volumes and is given byFig. 4. Impact of MS lesions: The subcortical segmentation of FIRST is robust even in presence o
matter and thalamus. (B) The segmentation (orange) is not impacted by the lesion.Eq. (2). A value of 0 means no overlap, whereas a value of 1 represents
a complete agreement.
s ¼ 2  ‖Vð2DÞ∩Vð3DÞ‖
Vð2DÞ þ Vð3DÞ ð2Þ
With ‖V(2D)∩V(3D)‖: modulus of overlap between V(2D) and V(3D).
In this study, the subcortical segmentation was performed on data
sets which were acquired in different orientations. Therefore, computa-
tion of Dice3s coefﬁcients is not possible per se. To enable the use of this
measure, we aligned the 2D data sets onto the respective 3D data sets
using FLIRT. The resulting afﬁne transformation parameters were then
applied to the segmented subcortical structures. Dice3s coefﬁcients be-
tween realigned 2D structures and 3D structures were calculated
using the routine @DiceMetric of AFNI (Cox, 1996).
The accuracy and reliability of the 2D data segmentation in compar-
ison to the 3D data segmentation were further tested by calculating
intra-class correlation coefﬁcients (ICCs). More speciﬁcally, we calculat-
ed ICC for the particular subcortical structures, for BG, and for thewhole
DGM. A two-way mixed model for single measures was used with data
acquisition (2D versus 3D) as ﬁxed factor and the subjects as random
factor. ICCs for consistency and for absolute agreement were calculated.
A high ICC for consistency means that if a volume is largest in the 3D
segmentation, it is highly probable that it is also largest in the 2D seg-
mentation. A high ICC in absolute value means in addition that the vol-
umes in both segmentations are nearly the same in terms of absolute
numbers (no systematic errors). High ICC in either case means that
both segmentation results have a similar predictive value in regression
analyses. In line with previous publications by Nugent et al. (2013)f MS lesions. The black arrow in (A) points to a hypo-intense lesion at the border of white
Table 1
Percentage volume differences for the different subcortical greymatter regions (number of subjects N=62). Basal ganglia: sumover caudate, putamen, pallidum, and nucleus accumbens;
deep grey matter (DGM): basal ganglia plus thalamus. Positive difference means that the segmented structures are larger in the 2D data sets.
Thalamus Putamen Pallidum Caudatus Nucleus accumbens Basal ganglia DGM
Mean difference 7.035 1.341 2.608 −8.303 −25.164 −2.705 1.348
Standard deviation 5.878 7.683 10.061 8.198 28.031 4.718 4.270
Most negative difference −16.320 −13.383 −29.778 −32.651 −106.977 −16.642 −15.921
Most positive difference 23.951 25.190 32.467 14.074 46.859 13.739 12.718
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agreement and ICC N 0.9 as strong agreement.
3. Results
After visual inspection of the registration to MNI space, the data of
eight patients (11.4%) had to be discarded (seven from the Avanto and
one from the Symphony). In four of these eight cases (5.7%; three on
the Avanto, one on the Symphony), both the registration of the 3D
and the 2D data failed. These patients demonstrated severe global
brain atrophy with much enlarged ventricles (Fig. 2 shows a typical ex-
ample). In the other four patients (5.7%; all Avanto), only the registra-
tion of the interpolated 2D data failed. Visual inspection of these data
sets revealed errors in the angulation of the co-registered data sets to
the MNI templates and/or gross scaling errors. Whereas in two of
these four patients no obvious reasonwas found, the other two patients
showed motion artefacts in the original 2D data sets. As the 2D data
were acquired in two interleaved concatenations, motion becomes ap-
parent in these cases as a displacement between the even and the odd
slices. The displacement artefacts were slightly blurred due to the spa-
tial interpolation, but were still manifest in the interpolated data (see
Fig. 3). None of the remaining patients (N = 62; 88.6%) showed either
major inaccuracies of the subcortical segmentation or failures in the
CSF mask. Furthermore, hypo-intense MS lesions located at the borders
of the particular subcortical structures had novisible impact on segmen-
tation (see Fig. 4). Therefore, all of the remaining data sets were includ-
ed in the statistical analysis.
Percentage volume differences between the segmentation of 2D and
of 3D data are shown in Table 1. Themean percentage differences for the
individual substructures were between 1.3% (putamen) and −25.2%
(nucleus accumbens). Maximal individual differences were up to 107%
(nucleus accumbens). Mean volume difference was−2.7% for BG (with
individual differences up to−16.6%) and 1.3% for the DGM (individual
differences up to 15.9%). The individual differences of BG and DGM are
shown in Fig. 5.
The impact of the CSFmasks was evaluated separately. From all sub-
structures, only the thalamus and the caudate nucleus were affected by
this correction as only these two substructures border to the lateral ven-
tricles (see also Fig. 6). Without the CSF masks, the mean difference for
the thalamus was 10.4 ± 6.7% (range −11.8%–27.6%); it dropped toFig. 5. Volume differences between 2 and 3D segmentation: Percentage volume differenc
BG+ thalamus). The 2D data were additionally corrected with a CSFmask (see Fig. 6). Solid lin7.0± 5.9% (range−16.3% to+24.0%) using the CSFmasks. For the cau-
date nucleus, the effects of the CSF masking were negligible (with and
without CSF masks: 8.3 ± 8.2%, range −14.1% to +32.6%). For the
DGM volume, mean difference dropped from 2.8 ± 4.8% (without CSF
masks) to 1.3 ± 4.3% (with CSF masks). The individual differences
ranged from−14.0% to 16.0% (without CSF masks) and from−15.9%
to 12.7% respectively (with CSF masks). In line with the prior results,
the CSF masks had only negligible impact on the BG volume.
Dice3s similarity coefﬁcients (percentage volume overlap) are
shown in Table 2. The highest mean volume overlap was found for the
thalamus (89.1 ± 2.9%), whereas the lowest was found for nucleus ac-
cumbens (61.5 ± 9.1%). The respective values for the BG were 84.1 ±
3.3% and for DGM 86.3 ± 3.0%. Again, the CSF masks changed only the
volume overlap of the thalamus (without: 88.5 ± 3.3%; with: 89.1 ±
2.9%) and the volume overlap of DGM (without: 86.1 ± 3.0%; with:
86.3 ± 3.0%). The individual Dice3s coefﬁcients for BG and DGM using
the CSF masks are depicted in Fig. 7.
ICCs for the particular subcortical structures and for BG and for DGM
are summarized in Table 3. All structures showed acceptable agreement
both for consistency and for absolute value except the nucleus accum-
bens. Regarding consistency, strong agreement was found in the thala-
mus (ICC = 0.936), BG (ICC = 0.922) and in DGM (ICC = 0.947);
regarding absolute value, total DGM volume (ICC = 0.944) showed
strong agreement. Again, the CSF mask had signiﬁcant impact only on
the ICC of the thalamus (consistency: ICC increased from 0.907 to
0.936; total agreement: ICC increased from 0.731 to 0.851) and on the
ICC of the total volume of DGM (consistency: ICC increased from 0.931
to 0.947; absolute value: ICC increased from 0.913 to 0.944).
The validation results of FIRST against the manual segmentation are
shown in Table 4 for the caudate and putamen. Themean volume differ-
ence between 3D FIRST andmanual segmentation was−11.03% for the
caudate (FIRST segmentation smaller) with individual differences be-
tween −22.5% and +4.6%. The respective results for the putamen
were 15.6% (FIRST segmentation larger) with individual differences be-
tween −4.5% and +34.2%. Mean overlap was 83.3% for the caudate
(with an individual range between 73.2% and 87.0%) and 85.8% for the
putamen (78.5%–90.1%). The respective ICCs were: caudate 0.92 (con-
sistency) and 0.74 (absolute value); putamen 0.87 (con) and 0.52 (abs).
For the 2D data, ICCs to manual segmentation were generally small-
er: caudate 0.83 (cons) and 0.52 (abs); putamen 0.72 (con) and 0.44e between 2 and 3D data for the basal ganglia (BG) and for deep grey matter (DGM;
e: mean difference for all patients; broken lines: mean difference± 2 ∗ standard deviation.
Fig. 6.CSFmask effect: The effect of applying a CSFmask onto 2Ddata; A: original DGMmask; B: CSFmask; C:DGMmask corrected for CSF; D: difference between originalmask (grey) and
corrected mask (orange). Only the thalamus (4) was signiﬁcantly impacted by the CSF mask. The other DGM structures in this ﬁgure are (1) caudate nucleus; (2): putamen; and (3):
pallidum.
48 M. Amann et al. / NeuroImage: Clinical 7 (2015) 43–52(abs). Mean difference was−20.1% for caudate (−33.8% to+ 2.4%) and
+14.2% for putamen (−4.5%–34.2%), mean volume overlap was 68.6%
for caudate (52.1%–77.5%) and 79.4% for putamen (67.7%–85.0%).
4. Discussion
In this study, we systematically evaluated the possibility of
segmenting subcortical grey matter structures using two-dimensional
T1-weightedMRI data sets with FIRST, a software tool that has been op-
timized for the segmentation of subcortical brain structures. Up to now,
only 2D T1-weighted data are acquired in most clinical trials on MS and
hence, a successful extension of the FIRST algorithm to this type of data
would enable to study subcortical changes in large patient cohorts and
to better understand effects of therapeutic interventions on DGM inMS.
4.1. Registration
The initial step when using FIRST is a registration to a common ste-
reotaxic space, which is deﬁned by the isotropic 1 mm3 MNI 152 tem-
plate (Fonov et al., 2011). Two problems arise by registering 2D data
sets onto this template. Namely, the 2D data sets have an anisotropic
spatial resolution with a relative large voxel size in slice direction (in
our case 3 mm) and, the spatial coverage is in general more limited
than that of the original 3D template, e.g. the medulla is usually not
covered. Our preliminary tests with non-interpolated 2D data showed
that registration failed when using the original voxel size of
0.9 × 0.9 × 3 mm3. Therefore, the spatial interpolation of the original
2D data to the voxel size of the MNI template (or at least to similar
voxel size) seems to be a prerequisite.
In an initial evaluation, we processed 25 data sets with the original
MNI template. The registration failed in approximately one third
(eight) of the interpolated 2D data sets because of large deviations in
angulation and/or gross scaling errors. The modiﬁcation of the original
MNI templates (whole brain template and template of the subcortical
structures) by “cutting off” the most superior and most inferior axial
slices reduced the number of failed registrations to MNI space to two
cases. In both of these cases, not only the registration of 2D data sets,
but also the registration of the 3D data sets failed. Both patients had se-
vere global brain atrophy with enlarged lateral ventricles. The fact that
severe atrophy hampers registration independent of the dimensionality
of data acquisition was reproduced for the rest of the patient cohort asTable 2
Volume overlap for the different subcortical grey matter regions (N= 62). Basal ganglia: sum o
ganglia plus thalamus.
Thalamus Putamen Pallidum
Mean overlap 0.891 0.857 0.796
Standard deviation 0.029 0.040 0.077
Minimal overlap 0.724 0.679 0.574
Maximal overlap 0.935 0.921 0.912we found two other cases in which both the registration for the 2D
and the 3D data failed due to severe atrophy. It is possible that replacing
the originalMNI 152 templatewith a new templatewith advanced atro-
phy may further reduce registration failures. However, the shape vari-
ance modelling of the subcortical structures in FIRST is speciﬁc to the
original template. Slight modiﬁcations of the original template (at
least when they are distant from the central structures of interest)
should not affect the modelling of the residual shape variance whereas
a replacement with an “atrophic” template would probably do so. Po-
tential segmentation failures due to advanced atrophy may be a limita-
tion of the FIRST routine, i.e. in longitudinal studies with a long follow-
up duration. However, as we could demonstrate here, this problem oc-
curs in both 2D and 3D data.
Based on our observations, motion artefacts can also impair the reg-
istration process. In 2D data acquisition, slices are often scanned in two
or more interleaved concatenations. In the case of two concatenations,
motion becomes apparent as a displacement between the even and
the odd slices, which can be observed as step-wise artefacts in slice di-
rection (Fig. 3). Spatial interpolation can reduce such artefacts, but
they still remain apparent. These artefacts may not only impair registra-
tion, but also affect tissue type segmentation and/or segmentation of
speciﬁc brain structures. One possibility to overcome this problem
could be the registration of the concatenations on each other before
any further processing. However, a careful ﬁxation of the patient3s
head to avoid motion artefacts is certainly preferable to any post-
processing.
In our study, the registration errors observed in two 2D data sets
(3%) could neither be explained by atrophy nor by motion artefacts.
The low number of such failures without clear reasonmakes it impossi-
ble to calculate any reasonable statistics concerning the inﬂuence of dif-
ferent MR scanner types onto data registration.
4.2. FIRST segmentation
In the data sets where MNI registration was working properly, we
did not ﬁnd major segmentation errors either in the 2D or in the 3D
data sets. Moreover, the subcortical segmentation using deformable
shape models in FIRST seems to be robust even in the presence of
hypointense MS lesions at the DGM/WM borders or within the struc-
tures itself (Fig. 4). Recently, it has been shown that themisclassiﬁcation
of voxels in intensity-based segmentation methods can impact thever caudate, putamen, pallidum, and nucleus accumbens; deep grey matter (DGM): basal
Caudatus Nucleus accumbens BG DGM
0.752 0.615 0.841 0.863
0.057 0.091 0.033 0.030
0.543 0.336 0.763 0.765
0.841 0.769 0.896 0.911
Fig. 7.Volumeoverlap between 2 and 3D segmentation: Percentage volumeoverlap (Dice3s coefﬁcient) between2 and 3Ddata for BGand forDGM. Solid line:meanoverlap for all patients.
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and Fisher, 2009). On the one hand, the DGM volume may be
underestimated in that WM lesions change the intensity threshold for
tissue segmentation. On the other hand, WM lesions adjacent to DGM
border may falsely increase the DGM volume due to neighbouring ef-
fects. Based on our qualitative observations, we consider the second ef-
fect as minor in our data. It cannot be ruled out that the DGM volume is
underestimated due to the impact of WM lesions, but both 2D and 3D
data should be affected in a similar way.4.3. Agreement between FIRST 2D and 3D segmentation
We calculated three quality measures comparing the subcortical
segmentation of (interpolated) 2D data to the standard segmentation
of 3D data: volume difference, volume overlap and intra-class correla-
tion coefﬁcients. Considering all three measures, total DGM volume as
well as the total volume of the BG and the thalamic volume can be reli-
ably estimated on 2D data sets with FIRST. In general, the thalamic vol-
ume is somewhat overestimated using the 2D data due to partial
volume effects caused by the relatively large slice thickness. This overes-
timation can be reduced by calculating an additional CSF mask. In our
study, the mean volume difference was reduced from 10.4% to 7.0%, al-
though in few cases the difference became larger after CSF correction
(mainly in those cases where the 2D segmentation yielded lower tha-
lamic volumes than the 3D segmentation). In contrast to the thalamus,
the segmentation of other structures did not beneﬁt from the correction
using the CSF mask.
The segmentation results for the putamen, pallidumand caudate nu-
cleus were performed with sufﬁcient quality on 2D data using FIRST,
with a slight volume overestimation of putamen and pallidum com-
pared to the respective volumes in 3D data and an underestimation of
the caudate volume. Such systematic variationswill not affect statistical
evaluations, if all study data are two-dimensional.Table 3
Intra-class coefﬁcients between 2 and 3D data volumes (N = 62). ICC values N 0.7 (bold)
are considered as acceptable agreement, ICC values N 0.9 (red) as strong agreement.
Pearson3s correlation coefﬁcients are shown for comparison.
Area 
Intra-class correlation 
coefficient ICC  (consistency)
Intra-class correlation 
coefficient ICC  (absolute 
value)
Pearsons correlation 
coefficient R
Caudatus 0.852 0.733 0.868
Pallidum 0.737 0.729 0.763
Putamen 0.825 0.823 0.831
Accumbens 0.634 0.464 0.676
Thalamus 0.936 0.851 0.939
Sum BG 0.922 0.899 0.932
Sum DGM 0.947 0.944 0.953The nucleus accumbens was segmented only with unsatisfactory
quality, not only in individual cases but also generally. This certainly re-
lates not only to the small size of the nucleus accumbens (themean vol-
ume of bilateral nucleus accumbenswas 780mm3 in our patient cohort,
the mean volume of bilateral thalamus was 14,450 mm3 for compari-
son), but also to the fact that the nucleus accumbens abuts to other
deep brain nuclei and therefore the delineation of its exact borders is
difﬁcult. Our results are in line with those of Morey et al. (2010) evalu-
ating scan–rescan reliability of FIRST. In this work, the authors also
found poor reliability for small subcortical structures such as the nucle-
us accumbens, but higher reliability in caudate, pallidum, putamen and
thalamus. Similar results were found for interscanner reliability and in
the comparison to manual segmentation in the work of Nugent et al.
(2013).4.4. Agreement between FIRST and manual segmentation
We used manual segmentation for validation of the FIRST results, as
it has been demonstrated that manual segmentations can account for
the variability of the underlying brain structures not only at a subcorti-
cal (Nugent et al., 2013), but also at a cortical level (Wengenroth et al.,
2014) (Seither-Preisler et al., 2014). Compared to the manual segmen-
tation, the volume of the caudate was systematically underestimated
with FIRST whereas the volume of the putamen was overestimated.
This is also reﬂected by the relatively low ICCs for absolute value. How-
ever, the ICCs for consistency reveal strong to moderate agreement be-
tween FIRST and the manual segmentation for both structures.
Compared to Nugent et al. (2013), the ICCs for consistency between
the manual segmentation and 3D FIRST segmentation were in the
same range, whereas the ICCs for absolute value were slightly higher
in our work.
For both caudate andputamen,meanoverlap and ICCswere lower in
2D versus manual segmentation than in 3D versus manual segmenta-
tion. This was expected, as the manual segmentation was based on the
3D data. However, the ICCs for consistency demonstrate still moderate
agreement between 2D and manual segmentation.
In contrast, the mean volume difference between the 3D and 2D
FIRST segmentation was smaller than between the manual and eitherTable 4
Comparison between the results of FIRST segmentation (both 2Dand 3D) andmanual seg-
mentation for a subset of 20 data sets. Manual segmentation was applied only to 3D data.
Mean difference Mean overlap ICC con ICC abs
Caudatus 3D −11.031 ± 6.000 0.833 ± 0.0273 0.915 0.743
2D −20.110 ± 7.926 0.686 ± 0.0678 0.827 0.468
Putamen 3D 15.569 ± 7.330 0.858 ± 0.0270 0.872 0.517
2D 14.217 ± 9.745 0.794 ± 0.0420 0.718 0.440
50 M. Amann et al. / NeuroImage: Clinical 7 (2015) 43–52FIRST segmentation in both structures, indicating the intra-model con-
sistency of FIRST independent from the input data.
4.5. Relevance of our results
The validation of FIRST on2Ddata sets appears important in the light
of large amounts of existing 2Ddata, which has been collected in the last
two decades in most clinical multiple sclerosis trials. In these trials 2D
data are preferred as semi-automatic data analysis (e.g. lesion marking
and segmentation) of 3D data is more time-consuming.
The present results are signiﬁcant in at least two aspects:
1. Up to now, only 2D T1-weighted data are acquired inmost clinical
trials on MS (i.e. glatiramer acetate (Rovaris et al., 2007),
Interferone-beta in secondary progressive MS (Molyneux et al.,
2000), Daclizumab (Gold et al., 2013), Natalizumab (Miller et al.,
2003; Rudick et al., 2006), Dimethyl fumarate (Kappos et al.,
2008), Atacicept (Kappos et al., 2014), or Fingolimod (Kappos
et al., 2010)) and hence, a successful extension of the FIRST algorithm
to this type of data would enable to study subcortical changes in
large patient cohorts and to better understand effects of therapeutic
interventions on DGM in MS.
Although the majority of studies on Alzheimer disease, Parkinson
disease or psychiatric disorders uses protocols with three-dimensional
T1 images, there are two-dimensional data on other neurological disor-
ders where FIRST could be applied, i.e. in studies with Neuromyelitis
optica (Kiyat-Atamer et al., 2013) or in MS natural history studies
(Pagani et al., 2005; Zivadinov et al., 2001).
2. Applying FIRST on (MS) patients at later stages of the disease with
pronounced degrees of brain atrophy (severely enlarged lateral ven-
tricles) results in registration failure in both 2D and 3Ddata sets. This
problem may be critical in applying FIRST to conditions with pro-
nounced brain atrophy, i.e. Alzheimer disease, Parkinson3s disease,
or vascular dementia as for the registration step, brain templates av-
eraged from brain images of young healthy subjects are used. This
issue raises a question whether a new “atrophic” template and the
re-adjustment of the FIRST algorithm (residual shape variance
modelling) to such a template would be needed in studies on pri-
marily neurodegenerative conditions. This issuemay at least partial-
ly be resolved (and hence percentage of successfully registered
images be increased) by applying the method suggested by Goodro
et al. (2012) who registered the MNI152 standard space template
using FSL3s FNIRT (FMRIB3s Nonlinear Image Registration Tool),
then processed the registered 3D-MRIs with FIRST and ﬁnally trans-
formed the registered images back to the original MRI-space (details
in Goodro et al. (2012)).
5. Conclusion
In conclusion,wewere able to demonstrate that subcortical GM seg-
mentation of interpolated 2D data with FIRST is comparable with the
segmentation of 3D data for larger deep grey matter areas. The results
of the total volume of the DGM and of the BG agree well with those de-
termined using the 3D data. Two slight modiﬁcations of the FIRST data
processing pipeline, namely a minor modiﬁcation of the MNI templates
as well as an additional spatial interpolation of the 2D data, improved
the number of successfully segmented data sets. The comparison be-
tween FIRST and manual segmentation revealed similar agreement be-
tween the two methods as between FIRST segmentation of 2D and 3D
data. Taken together, our data indicate that FIRST is suitable for the seg-
mentation of 2D data sets acquired in multicentre studies in MS if ap-
propriate quality control assessments are performed.Acknowledgements
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